Share on StockTwits

Teleflex (NYSE:TFX) is scheduled to be releasing its Q114 earnings data on Wednesday, April 30th. Analysts expect Teleflex to post earnings of $1.16 per share and revenue of $433.20 million for the quarter. Teleflex has set its FY14 guidance at 5.35-5.55 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Friday, February 21st. The company reported $1.36 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.27 by $0.09. The company had revenue of $450.50 million for the quarter, compared to the consensus estimate of $437.06 million. On average, analysts expect Teleflex to post $5.51 EPS for the current fiscal year and $6.42 EPS for the next fiscal year.

Shares of Teleflex (NYSE:TFX) opened at 100.84 on Tuesday. Teleflex has a 1-year low of $73.83 and a 1-year high of $109.73. The stock’s 50-day moving average is $104.0 and its 200-day moving average is $96.90. The company has a market cap of $4.156 billion and a price-to-earnings ratio of 29.11.

Several analysts have recently commented on the stock. Analysts at KeyCorp initiated coverage on shares of Teleflex in a research note on Wednesday, April 9th. They set a “hold” rating on the stock. On a related note, analysts at Barclays raised their price target on shares of Teleflex from $105.00 to $115.00 in a research note on Monday, March 24th. They now have an “equal weight” rating on the stock. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Teleflex in a research note on Wednesday, March 19th. They now have a $120.00 price target on the stock, up previously from $114.00. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $110.83.

Teleflex Incorporated (NYSE:TFX) is a global provider of medical technology products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.